Panton-Valentine leukocidin (PVL) gene carriage among Staphylococcus aureus strains with SCCmec types I, III, IV, and V recovered from cystic fibrosis pediatric patients in Brazil

Diagnostic Microbiology and Infectious Disease

Volumn 78, Issue 1, 2014, Pages 59-62

  Lima, Danielle Ferreira ^a   Brazão, Nathalia Brito Veloso ^a   Folescu, Tania Wrobel ^b   Neves, Felipe Piedade ^c   Ferreira, Alex Guerra ^a   Santos, Erica Aparecida ^d   Marques, Elizabeth Andrade ^a,d   Leão, Robson Souza ^a  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Cystic fibrosis; MLST; MRSA; PVL; SCCmec; Staphylococcus aureus

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRAZIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISK DIFFUSION; GENE CASSETTE; GENE IDENTIFICATION; HETEROZYGOTE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PVL GENE;

CYSTIC FIBROSIS; MLST; MRSA; PVL; SCCMEC; STAPHYLOCOCCUS AUREUS;

BACTERIAL TOXINS; BRAZIL; CYSTIC FIBROSIS; EXOTOXINS; GENOTYPE; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 84890118712     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.10.004     Document Type: Article

References (44)

1. Al-Talib H., Yean C.Y., Al-Khateeb A., Hassan H., Singh K.K., Al-Jashamy K., et al. A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin. BMC Microbiol 2009, 28:9-113.
2. Boye K., Bartels M.D., Andersen I.S., Møller J.A., Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect 2007, 13:725-727.
3. Caboclo R.M., Cavalcante F.S., Iorio N.L., Schuenck R.P., Olendzki A.N., Felix M.J., et al. Methicillin-resistant Staphylococcus aureus in Rio de Janeiro hospitals: dissemination of the USA400/ST1 and USA800/ST5 SCCmec type IV and USA100/ST5 SCCmec type II lineages in a public institution and polyclonal presence in a private one. Am J Infect Control 2013, 41:e21-e26.
4. Cafiso V., Bertuccio T., Spina D., Campanile F., Bongiorno D., Santagati M., et al. Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2010, 29:1277-1285.
5. Campana S., Cocchi P., Döring G., Taccetti G., Moroney S.M. Emergence of an epidemic clone of community-associated methicillin-resistant panton-valentine leucocidin-negative Staphylococcus aureus in cystic fibrosis patient populations. J Clin Microbiol 2007, 45:3146.
6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for antimicrobial susceptibility testing. (M100-S20). Wayne, PA: CLSI; 2010.
7. Cocchi P., Cariani L., Favari F., Lambiase A., Fiscarelli E., Gioffré F.V., et al. Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview. J Cyst Fibros 2011, 10:407-411.
8. Dasenbrook E., Checkley W., Merlo C., Konstan M., Lechtzin N., Boyle M. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. J. Am. Med. Assoc. 2010, 303:2386-2392.
9. Denis O., Nonhoff C., Byl B., Knoop C., Bobin-Dubreux S., Struelens M.J. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. J Antimicrob Chemother 2002, 50:383-391.
10. dos Santos Soares M.J., da Silva-Carvalho M.C., Ferreira-Carvalho B.T., Figueiredo A.M. Spread of methicillin-resistant Staphylococcus aureus belonging to the Brazilian epidemic clone in a general hospital and emergence of heterogenous resistance to glycopeptide antibiotics among these isolates. J Hosp Infect 2000, 44:301-308.
11. Dumitrescu O., Badiou C., Bes M., Reverdy M.E., Vandenesch F., Etienne J., et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect 2008, 4:384-388.
12. Earley M.A., Friedel M.E., Govindaraj S., Tessema B., Eloy J.A. Community-acquired methicillin-resistant Staphylococcus aureus in nasal vestibular abscess. Int Forum Allergy Rhinol 2011, 1:379-381.
13. Endimiani A., Blackford M., Dasenbrook E.C., Reed M.D., Bajaksouszian S., Hujer A.M., et al. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland Ohio. Antimicrob Agents Chemother 2011, 55:1684-1692.
14. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
15. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004, 186:1518-1530.
16. Filleron A., Chiron R., Reverdy M.E., Jean-Pierre H., Dumitrescu O., Aleyrangues L., et al. Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients. J Cyst Fibros 2011, 10:377-382.
17. Gales A.C., Sader H.S., Andrade S.S., Lutz L., Machado A., Barth A.L. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. Int J Antimicrob Agents 2006, 27:300-302.
18. Gilligan P.H., Kiska D.L., Appleman M.D. Cumitech 43, Cystic Fibrosis Microbiology 2006, ASM Press, Washington, D.C, M.D.Appleman. Coordinating ed.
19. Glikman D., Siegel J.D., David M.Z., Okoro N.M., Boyle-Vavra S., Dowell M.L., et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus. Chest 2008, 133:1381-1387.
20. Goodrich J.S., Sutton-Shields T.N., Kerr A., Wedd J.P., Miller M.B., Gilligan P.H. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 2009, 47:1231-1233.
21. Grupo Brasileiro de Estudos de Fibrose Cística (GBFC). Registro Brasileiro de Fibrose Cística. 1o Relatório Anual. Ano 2009. http://www.mlst.net http://www.sccmec.org.
22. Klevens R.M., Morrison M.A., Fridkin S.K., Reingold A., Petit S., Gershman K., et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006, 12:1991-1993.
23. Larsen A.R., Stegger M., Böcher S., Sørum M., Monnet D.L., Skov R.L. Emergence and characterization of community-associated methicillin-resistant Staphylococcus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 2009, 47:73-78.
24. Lavergne S.N., Whitaker P., Peckham D., Conway S., Park B.K., Naisbitt D.J. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis. Chem Res Toxicol 2010, 23:1009-1011.
25. Leahy TR, Yau YC, Atenafu E, Corey M, Ratjen F, Waters V. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis. Pediatr. Pulmonol. 2011:Feb 17.
26. Liskov R.L., Han X., Larsen A.R., Larsen J., Sorum M., Wulf M., et al. Novel types of staphylococcal cassette chromosome mec elements identified in clonal complex 398 methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2011, 55:3046-3050.
27. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
28. Maree C.L., Daum R.S., Boyle-Vavra S., Matayoshi K., Miller L.G. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007, 13:236-242.
29. Mediavilla J.R., Chen L., Mathema B., Kreiswirth B.N. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol 2012, 15:588-595.
30. Milheiriço C., Oliveira D.C., de Lencastre H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: 'SCCmec IV multiplex'. J Antimicrob Chemother 2007, 60:42-48.
31. Mimica MJ, Berezin EN, Damaceno N, Carvalho RB. SCCmec type IV, PVL-negative, methicillin-resistant Staphylococcus aureus in cystic fibrosis patients from Brazil. Curr. Microbiol. 2011;62:388-90.
32. Muhlebach M.S., Miller M., LaVange L.M., Mayhew G., Goodrich J.S., Miller M.B. Treatment intensity and characteristics of MRSA infection in CF. J Cyst Fibros 2011, 10:201-206.
33. Otto M. Community-associated MRSA: what makes them special?. Int J Med Microbiol 2013, 303:324-330.
34. Reiter K.C., Machado A.B., Freitas A.L., Barth A.L. High prevalence of methicillin-resistant Staphylococcus aureus with SCCmec type III in cystic fibrosis patients in southern Brazil. Soc Bras Med Trop 2010, 43:377-381.
35. Ribeiro A., Coronado A.Z., Silva-Carvalho M.C., Ferreira-Carvalho B.T., Dias C., Rozenbaum R., et al. Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clones in Rio de Janeiro and Porto Alegre cities causing both community and hospital-associated diseases. Diagn Microbiol Infect Dis 2007, 59:339-345.
36. Sanchini A, Spitoni MG, Monaco M, Raglio A, Grigis A, Petrò W, Menchini M, Pesenti A, Goglio A, Pantosti A. Outbreak of skin and soft tissue infections in a hospital newborn nursery in Italy due to community-acquired meticillin-resistant Staphylococcus aureus USA300 clone. J. Hosp. Infect. 2013; 83:36-4.
37. Santos R.P., Prestidge C.B., Brown M.E., Urbancyzk B., Murphey D.K., Salvatore C.M., et al. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis. Pediatr Pulmonol 2009, 44:148-154.
38. Saravolatz L.D., Pohlod D.J., Arking L.M. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982, 97:325-329.
39. Schuenck R.P., Nouér S.A., Winter C.O., Cavalcante F.S., Scotti T.D., Ferreira A.L., et al. Polyclonal presence of non-multiresistant methicillin-resistant Staphylococcus aureus isolates carrying SCCmec IV in health care-associated infections in a hospital in Rio de Janeiro. Brazil Diagn Microbiol Infect Dis 2009, 64:434-441.
40. Scribel L.V., Silva-Carvalho M.C., Souza R.R., Superti S.V., Kvitko C.H., Figueiredo A.M., et al. Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus carrying SCCmecIV in a university hospital in Porto Alegre. Brazil. Diagn. Microbiol. Infect. Dis. 2009, 65:457-461.
41. Sousa-Junior F.C., Silva-Carvalho M.C., Fernandes M.J., Vieira M.F., Pellegrino F.L., Figueiredo A.M., et al. Genotyping of methicillin-resistant Staphylococcus aureus isolates obtained in the Northeast region of Brazil. Braz J Med Biol Res 2009, 42:877-881.
42. Taccetti G., Campana S., Neri A.S., Boni V., Festini F. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis. J Chemother 2008, 20:166-169.
43. Yurdakul P., Ocal H.Y., Gulmez D., Yalcin E., Dogru D., Cinel G., et al. Predominance of hospital-associated MRSA among cystic fibrosis patients in a Turkish reference cystic fibrosis centre. J Chemother 2012, 24:195-200.
44. Zetola N., Francis J.S., Nuermberger E.L., Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.